Quarterly report pursuant to Section 13 or 15(d)

Share-based Payments - Summary of Stock Options Activity (Details)

v3.10.0.1
Share-based Payments - Summary of Stock Options Activity (Details)
9 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Number of Shares, Beginning Balance | shares 31,875
Number of Shares, Granted | shares
Number of Shares, Exercised | shares
Number of Shares, Forfeited | shares (21,375)
Number of Shares, Cancelled/Expired | shares
Number of Shares, Ending Balance | shares 10,500
Number of Shares, Exercisable | shares 10,500
Weighted Average Exercise Price, Beginning Balance $ 34.00
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited 35.76
Weighted Average Exercise Price, Cancelled/Expired
Weighted Average Exercise Price, Ending Balance 30.40
Weighted Average Exercise Price, Exercisable 30.40
Weighted Average Grant Date Fair Value, Beginning 20.48
Weighted Average Grant Date Fair Value, Granted
Weighted Average Grant Date Fair Value, Exercised
Weighted Average Grant Date Fair Value, Forfeited 22.00
Weighted Average Grant Date Fair Value, Cancelled/Expired
Weighted Average Grant Date Fair Value, Ending 17.44
Weighted Average Grant Date Fair Value, Exercisable $ 17.44
Weighted Average Remaining Contractual Term (Years), Beginning 2 years 7 days
Weighted Average Remaining Contractual Term (Years), Granted 0 years
Weighted Average Remaining Contractual Term (Years), Exercised 0 years
Weighted Average Remaining Contractual Term (Years), Forfeited 1 year 26 days
Weighted Average Remaining Contractual Term (Years), Cancelled/Expired 0 years
Weighted Average Remaining Contractual Term (Years), Ending 1 year 8 months 9 days
Weighted Average Remaining Contractual Term (Years), Exercisable 1 year 8 months 9 days
Aggregate Intrinsic Value, Beginning Balance | $
Aggregate Intrinsic Value, Ending Balance | $
Aggregate Intrinsic Value, Exercisable | $